Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

Ngā tūemi rite

• Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
  mā: Hideshima, Teru, me ētahi atu.
  I whakaputaina: (2006)
• MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth <i>In vitro</i> and <i>In vivo</i>
  mā: Teru Hideshima, me ētahi atu.
  I whakaputaina: (2006)
• Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
  mā: Noopur Raje, me ētahi atu.
  I whakaputaina: (2004)
• Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells
  mā: Teru Hideshima, me ētahi atu.
  I whakaputaina: (2007)
• Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells
  mā: Hideshima, Teru, me ētahi atu.
  I whakaputaina: (2009)